ANN ARBOR, Mich., Jan. 17, 2008 (PRIME NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM) ), a leading regenerative medicine company, today announced that George Dunbar, President and Chief Executive Officer, will participate in the Leerink Swann Novel Biologics Therapeutics Roundtable Conference on Thursday, January 24, 2008 at 2:15 pm (EDT). The conference will be held January 24th at the Le Parker Meridien Hotel in New York City.
